IBM’s $12.5 Billion AI Backlog and a White House Quantum Mandate Create a Two-Front Growth Story
Published on 06/23/2026 at 15:26 | Redaktion boerse-global.de
IBM shares climbed 3.23% to €228.50 on Tuesday, extending a recovery from a brutal selloff that wiped nearly a quarter off the stock since June. The rebound comes as investors begin to untangle two distinct narratives: a punishing macro environment that unfairly dragged down the technology giant, and a pair of concrete growth catalysts that are now coming into sharper focus.
The June rout was never about IBM’s own numbers. A guidance cut from Accenture for fiscal 2026 infected the entire IT sector with fear of slowing demand, even though IBM’s business mix is fundamentally different. Consulting accounts for less than a third of its revenue, while high-margin software drives growth. The market, in other words, punished the wrong company. Add to that a hawkish signal from the Federal Reserve under new chair Kevin Warsh in mid-June, and the stock lost more than 20% from its early-June record high.
Yet beneath the noise, the underlying business has been quietly strengthening. In the first quarter of 2026, IBM posted revenue of $15.9 billion, up 9% year-on-year. Software revenue jumped 11% to $7.1 billion, led by a 19% surge in data-related products. Even the mainframe Z platform, which powers secure real-time calculations for financial institutions, grew 48%.
The AI Order Book Is No Longer Hypothetical
Perhaps the most tangible sign of momentum is the swelling backlog for generative AI. IBM now holds over $12.5 billion in signed contracts for artificial intelligence, with generative AI making up roughly 30% of the total order book. These are not vague pipeline projections; they are executed agreements with customers deploying AI in production environments.
Should investors sell immediately? Or is it worth buying IBM?
To accelerate that deployment, IBM deepened its partnership with ServiceNow in mid-June. The two companies are jointly tackling the biggest bottleneck for enterprise AI: outdated applications and unstructured data. IBM is integrating its own technologies into ServiceNow’s AI platform, with the first joint solutions expected in the second half of 2026. It is a classic “connective tissue” play — making IBM indispensable by modernising the infrastructure that companies are reluctant to rip and replace.
A Quantum Boost from Washington
While AI orders drive near-term revenue, a separate catalyst emerged from the White House on Monday. President Donald Trump signed two executive orders on quantum technology, with IBM CEO Arvind Krishna standing beside him. The decrees set an ambitious two-year target for building an advanced quantum computer and mandate that all federal agencies adopt quantum-safe encryption by 2031 — four years earlier than previous deadlines.
IBM is already positioned to benefit. In May, the company announced a joint venture with the Commerce Department called Anderon, which will become America’s first dedicated quantum foundry. The government is contributing $1 billion from the CHIPS Act, while IBM is adding another $1 billion in cash and valuable patents. Separately, IBM disclosed in a regulatory filing that it will invest more than $10 billion over the next five years to deliver a fault-tolerant quantum computer by 2029.
The accelerated encryption deadline creates an immediate market for IBM’s security software, such as the zSecure Secret Manager, which automates certificate replacement. Federal agencies that once had until 2035 now have only until 2031, filling IBM’s security pipeline with urgent demand.
The Consulting Drag Remains
Despite these tailwinds, IBM’s consulting business continues to lag. The segment grew just 4% in the first quarter to $5.3 billion, as clients remained cautious with new projects. That weakness has weighed on investor sentiment, even as the quantum news triggered a brief after-hours spike of up to 6% in the stock.
IBM at a turning point? This analysis reveals what investors need to know now.
Year to date, IBM shares are still roughly 11% in the red. The current price sits around €228.50, above the 50-day moving average but below the long-term trendline of €235.65. The relative strength index (RSI) hovers near 50, indicating neutral momentum.
Analysts remain broadly bullish. The average price target stands at €253.81, implying significant upside from current levels. But the path back to the June highs will be volatile. With annualised volatility above 67% and a Fed that is still tightening, IBM’s stock is likely to swing hard in both directions.
For now, the company has two powerful engines — a $12.5 billion AI backlog and a White House-backed quantum mandate — that could eventually overcome the headwinds from a cautious consulting business and a jittery market. The question is whether investors will wait long enough to see them fully ignite.
Ad
IBM Stock: New Analysis - 23 June
Fresh IBM information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
